Recent Articles from GlobeNewswire

Acquisition Connects Wholesale, Online Retail Storefronts and On-Demand Fulfillment to Create a More Unified Commerce Ecosystem for Golf Brands, Green-Grass Facilities and PGA Professionals

Company honors service companies and technicians for excellence in the commercial foodservice equipment industry

Preece to carry the organization’s original number, building upon a legacy that began with Mark Martin in 1988

In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Good Life Meds, LLC discontinue the challenged express health benefit and personalization claims for its compounded Tirzepatide+ products and modify its advertising to avoid conveying unsupported implied claims about product safety, efficacy, weight loss results, and personalization.

Cap provides financing for upcoming feature film Wake, demonstrating how its underwriting model can support specialized credit markets without requiring real-world assets to be tokenized.

Shaped by 15,000 beta users, the platform co-founded by Tanner Foust, Emelia Hartford, and Michael George joins traditional automotive media with exclusive original programming and a new approach to connecting creators and enthusiasts

Voters have indicted the administration’s profiteering, now Congress needs to deliver on investigations

PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Amdocs Limited ("Amdocs" or the "Company") (NASDAQ: DOX) following the Company’s November 3, 2026 disclosures concerning a contractual dispute with T-Mobile and its fiscal 2027 financial outlook.

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company developing Multispecific™ therapeutics in oncology, today announced that updated clinical data from the Phase 1 study of ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma (RRMM) will be presented as an oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting.

TWLO stock dropped over 17% as the market repriced organic growth from 16% to a guided 11% to 12%. Levi & Korsinsky is investigating potential securities law violations on behalf of shareholders who lost money in the decline

Recognition highlights Inriver’s role as the trusted product data foundation for SAP Autonomous CX

NPKI shares declined following NPK International's October 29 earnings report, which disclosed full-year 2026 revenue guidance approximately $17 million below Wall Street expectations. Levi & Korsinsky is investigating potential securities law violations affecting investors who lost money

Intel's fourth-quarter 2026 revenue outlook of approximately $15 billion to $16 billion came in below Wall Street consensus as PC-market softness weighed on the Company. An investigation into potential securities law violations is underway on behalf of shareholders who lost money

ATEC shares sold off after Alphatec Holdings named a temporary international supply constraint among the reasons for its lower 2026 revenue outlook. Levi & Korsinsky is investigating whether the Company's earlier disclosures about its international business met its obligations under the federal securities laws

The upgraded Subtitle Mode within Vmake Labs video watermark remover is designed for advanced subtitle and overlay cleanup for video localization, dubbing, and creative reuse workflows.

Lineup Highlighted by returning R-Series, MT, and XSR Motorcycles

Talkdesk’s 2026 AI Holiday Shopping Survey highlights a growing divide between retail AI ambitions and consumer trust

Vik Rajagopal joins as CFO and Jensen Harris as President of Marketplace, Product, and Technology, as Rover continues to build the most trusted brand in pet care

Case Teams Can Now QC Productions and Inspect Incoming Data Inside CI Transfer — No Downloads, No Local Copies

San Antonio, Seattle and Nashville see significant gains in NAR's Q3 2026 Commercial Real Estate Demand Index as industrial employment growth drives stronger demand signals in select markets

FLORENCE, Italy and KRAKOW, Poland, Nov. 04, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, along with Ryvu Therapeutics (WSE: RVU), today announced that the first clinical data from the ongoing Phase II JASPIS-01 study (NCT06534437) of dapolsertib (MEN1703, SEL24) in patients with r/r aggressive B-NHL will be presented in a poster session at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 12-15, 2026, in New Orleans, Louisiana, and virtually.

MLS-owned venture now covers about nearly 70% of U.S. listings and targets 90%+ to deliver the most complete, timely active listing data to banks, insurers, GSEs and the platforms who serve these institutional buyers. REdistribute will meet with MLSs and brokers at NAR NXT in New Orleans, November 6-8.

The luxury retailer celebrates its expanding global community, recent designer additions, and a commitment to considered curation supported by direct designer relationships and owned inventory

GUANGZHOU, China, Nov. 04, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Advanced Air Mobility (“AAM”) technology platform company, today unveiled the EH216-EK, a firefighting pilotless electric vertical take-off and landing (“eVTOL”) aircraft with high-payload airdrop deployment, designed for aerial firefighting in early-stage forest and grassland fires, as well as fire emergencies at large industrial parks and warehousing and logistics facilities. EH216-EK features a multi-channel fire-extinguishing payload release system for high-payload, multi-point aerial fire suppression, further expanding EHang’s portfolio of solutions for emergency response.

IBM i teams can now convert their own RPG applications to Java with 1,000 free credits, or have Fresche run the modernization end-to-end through Modernization-as-a-Service

Leading toy manufacturer introduces official fidget-trading playmat and licensed toy collection inspired by Mrs. Bench’s signature style and community

New industry analysis shows Excess & Surplus lines direct premium growth moderating after years of record expansion, while underwriting profitability and insurer financial strength remain strong

Powered by Atmo AI and Vaisala observations, the compact system runs state-of-the-art forecasts without a supercomputer, in the customer's own environment and under its own control. 

MGX-001 data establish preclinical proof-of-concept in hemophilia AOn track to initiate global clinical trial in 2027

Completion of sentinel cohort enrollment triggers independent Data and Safety Monitoring Board review, a required milestone before initiation of the 243-patient randomized controlled phase

September data dropped 0.6 points as warehouses filled back up and available warehouse space contracted at its fastest rate in over four years

HONG KONG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Magic Empire Global Limited ("MEGL" or the "Company", Nasdaq: MEGL) today announced that it has secured a dedicated credit facility of US$100 million (the "Facility") from Anyu International Limited ("AIL") to fund its cross-border timber supply chain trading business. The Facility provides dedicated, medium-term capital support for the Company's timber procurement and cross-border trade settlement, and marks another concrete step in MEGL's strategic transformation into commodity trade and the timber industrial supply chain.

LONDON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), which is building the AI prediction infrastructure for global FMCG trade, today announced that Justin Floyd, Chief Executive Officer, will attend and host one-on-one meetings at the 15th Annual ROTH Technology Conference November 17-18, 2026 in New York City.

–  Data will be presented on Monday, December 14, 2026 at 11:15 AM CDT –

LONDON and GAITHERSBURG, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced the online publication of abstracts submitted to the American Society of Hematology (ASH) Annual Meeting, to be held December 12-15, 2026, in New Orleans, Louisiana.

CAMBRIDGE, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, today announced that two of its T cell engager programs, CLN-049, a FLT3xCD3 T cell engager, and velinotamig (CLN-803), a BCMAxCD3 T cell engager, will be featured across four poster presentations at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 12-15 in New Orleans, Louisiana.

-- New Sensolus index tracks how industrial assets move between suppliers and factories, finding more movement in the U.S. and a growing share of idle assets in Europe --

WATERTOWN, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple programs in its portfolio at the upcoming American Society of Hematology (ASH) Annual Meeting, which will be held in New Orleans, LA on December 12-15, 2026.

First clinical data for sutacimig in Factor VII deficiency (FVIID) shows multi-fold accumulation of endogenous FVII(a) with shortening of prothrombin time after a single subcutaneous dose in initial participants of the Phase 2b study

Eligible U.S. Feedonomics customers can now use the Merchant Workspace to connect their catalogs to Shop Direct and reach shoppers searching for their products

As Ultraviolette exhibits at EICMA 2026 in Milan, expanded partnership scales in-helmet voice control and advances agentic AI roadmap with OASYS

New and existing marketers can earn an extra $20 per qualified paid referral, with no cap on bonuses, on top of commissions of up to 30%

Chicago, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leader in turning consumer data into growth, today announced the launch of its new Concept Testing and Forecasting Solutions in the U.S. The offering includes two connected solutions, the Innovation Screener and the Concept Testing Suite. Together, they combine research with participants sourced from Circana’s active panel of 500,000 verified buyers with Circana predictive analytics to help brands identify their strongest new product development ideas and predict commercial potential before committing to launch. These panelists share actual purchasing behavior through receipts, online purchase information, apps, and other sources, allowing Circana to select research participants based on purchasing history combined with demographics and physiographic information.  

Six new Everform® Solid Surface designs and twelve new Homapal® Metal Laminate decors create additional surfacing options for inspired interiors

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that it has entered into a securities purchase agreement for a private placement of approximately $80 million of its common stock. The investors include ARCH Venture Partners, Adage Capital Management LP, Caligan Partners LP, RTW Investments, a leading mutual fund and other new and existing institutional investors.

The platform combines specialized AI agents with automation, real-device infrastructure, reporting, and integrations while allowing enterprises to retain existing test frameworks and choose how testing is deployed

FALLS CHURCH, Va., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) will participate in the Baird 2026 Global Industrial Conference on Wednesday, November 11. Kathy Warden, chair, chief executive officer and president will present beginning at 10:40 a.m. Eastern time. The presentation will be webcast live at http://investor.northropgrumman.com.

Gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell reconstitution, maintained in the absence of background therapy for autoimmune cytopenias, consistent with an “immune reset”

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that two abstracts featuring positive updated clinical data for rondecabtagene autoleucel (ronde-cel) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 12–15, 2026, in New Orleans (ASH 2026).

Preclinical data supporting CITY-TFR2 for anemia of chronic disease to be presented in a poster session

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 14, 2026, from 7:00–8:30 a.m. CT / 8:00–9:30 a.m. ET during the 68th American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss key data presented at the ASH meeting.

Independent, employee-driven award affirms the people-first culture powering ConsumerDirect's innovation in consumer financial technology

-- Building on previously presented DMR-001 preclinical data in Type 1 and Type 2 CALR mutations,new data to highlight strong activity against additional non-Type 1 mutations --

11th Annual Associations Trends Research Report finds 67% of members say using AI shows an association is innovative, while integrating AI ranks last among association professionals’ priorities

BEACON Trial Results Selected for Official ASH Press Program

Former Qualtrics Chief Transformation Officer joins the AvePoint Executive Leadership Team to deepen customer value and accelerate growth as enterprises scale AI with trust

WELLESLEY HILLS, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that it will present new clinical data for budoprutug in immune thrombocytopenia (ITP) at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, which will be held in New Orleans, Louisiana from December 12-15, 2026.

Verizon Powers the 2026 NFL Season with Stadium Upgrades and Global Private Wireless Network

SANTA CLARA Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Netskope (NASDAQ: NTSK), a leader in modern security and networking for the cloud and AI era, today announced that it will release financial results for its fiscal third quarter ended October 31, 2026, after the market closes on Wednesday, December 2, 2026.

BERKELEY, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU) today announced that vispa-cel and CB-011 clinical abstracts have been accepted for two oral presentations and one poster presentation at the 2026 American Society of Hematology (ASH) Annual Meeting, which will be held December 12-15, 2026 in New Orleans, Louisiana.

BRIDGEWATER, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that multiple abstracts were accepted for the 2026 American Society of Hematology (ASH) Annual Meeting, taking place December 12–15 in New Orleans, Louisiana. The presentations will highlight new clinical and real-world analyses of CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) in multiple myeloma, as well as updated data from Legend Biotech’s next-generation cell therapy programs. The program includes two oral presentations, four posters, and an additional ePublication.

– 14 accepted revumenib abstracts, including 7 for oral presentation, reinforce Syndax’s scientific leadership in menin inhibition –

The limited-edition Truly Potluck Pack is a custom mix of flavors built to pair with your specific menu, crew and vibe

New research tracks how paid search now splits across ChatGPT, Google AI Overviews, and traditional search heading into peak season

The Remitly Global Card is the world's first card that allows its users to text money and send money within the U.S. and to 175 countries, across 5 billion bank, cash, and wallet accounts

Global Clue study of almost 12,000 people reveals widespread menstrual health challenges, with one in three who sought medical care told their symptoms were normal or not a problem.

Updated CLOVER WaM Phase 2b analyses show durable responses in heavily pretreated patients and suggest greater benefit when used earlier in treatment paradigm

Integration helps shared customers connect telematics data with maintenance workflows through automated odometer, engine-hour and diagnostic trouble code updates

JACKSONVILLE, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Kevin Boone, will address the 2026 Baird Global Industrial Conference in Chicago on Wednesday, November 11, at 10:05 a.m. Eastern time.

Madrid, Spain and Tel Aviv, Israel, November 4, 2026 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”) a leading online gaming operator in Spain and Latin America, today announced that it will release its third quarter 2026 results prior to 8:30AM US Eastern Time on November 12, 2026.

DENVER, Nov. 04, 2026 (GLOBE NEWSWIRE) -- PureSky Energy, a leading owner and operator of community solar and distributed renewable energy assets across the United States, announced that it achieved an overall GRESB Infrastructure Asset Score of 93.8 in the 2025 assessment, an increase of 4.4 points year over year and an improvement in its GRESB rating to three stars.

Company Achieves Important Capital Markets Milestone Following Restoration of SEC Reporting Compliance

Full-Service Security and Safety Integration Company Connects Security, Safety and Critical Communications Through One Accountable Partner

Industry-governed trust infrastructure gains traction as financial institutions prepare for November and December implementation deadlines